These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9467043)

  • 1. Race and the Will Rogers phenomenon in prostate cancer.
    Vijayakumar S; Vaida F; Weichselbaum R; Hellman S
    Cancer J Sci Am; 1998; 4(1):27-34. PubMed ID: 9467043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.
    Vijayakumar S; Weichselbaum R; Vaida F; Dale W; Hellman S
    Cancer J Sci Am; 1996; 2(4):225-33. PubMed ID: 9166537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
    Jani AB; Vaida F; Hanks G; Asbell S; Sartor O; Moul JW; Roach M; Brachman D; Kalokhe U; Muller-Runkel R; Ray P; Ignacio L; Awan A; Weichselbaum RR; Vijayakumar S
    Int J Cancer; 2001 Dec; 96(6):363-71. PubMed ID: 11745507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.
    Vijayakumar S; Winter K; Sause W; Gallagher MJ; Michalski J; Roach M; Porter A; Bondy M
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):17-25. PubMed ID: 9422553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
    Asbell SO; Vijayakumar S
    Prostate; 1997 Apr; 31(1):42-6. PubMed ID: 9108885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
    Zagars GK; Pollack A; Pettaway CA
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
    Abdalla I; Ray P; Vaida F; Vijayakumar S
    Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
    Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
    J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
    Vijayakumar S; Karrison T; Weichselbaum RR; Chan S; Quadri SF; Awan AM
    Cancer Epidemiol Biomarkers Prev; 1992; 1(7):541-5. PubMed ID: 1284591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.
    Reed A; Ankerst DP; Pollock BH; Thompson IM; Parekh DJ
    J Urol; 2007 Nov; 178(5):1929-32; discussion 1932. PubMed ID: 17868724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of clinically significant prostate cancer in African Americans increased significantly following the 2012 US Preventative Services Task Force recommendation against prostate specific antigen screening: A Single Institution Retrospective Study.
    Arace J; Flores V; Monaghan T; Robins D; Karanikolas N; Winer A; Weiss J
    Int J Clin Pract; 2020 Feb; 74(2):e13447. PubMed ID: 31750596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
    Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
    J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
    Wenzel M; Nocera L; Collà Ruvolo C; Würnschimmel C; Tian Z; Shariat SF; Saad F; Briganti A; Tilki D; Graefen M; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
    J Urol; 2021 Jul; 206(1):69-79. PubMed ID: 33683934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.
    Thatai LC; Banerjee M; Lai Z; Vaishampayan U
    Urology; 2004 Oct; 64(4):738-43. PubMed ID: 15491712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.